DOC1021 Dendritic Cell Immunotherapy for Treatment of Newly Diagnosed Adult Glioblastoma (GBM)

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE2

מצבים רפואיים

Glioblastoma (GBM)

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים

Banner MD Anderson Cancer Center, Gilbert, Arizona, United States
Contact: Study coordinator (James Schohn) · James.Schohn@bannerhealth.com · 6025213700
Contact: Principal Investigator (Ramya Tadipatri, MD)
City of Hope, Duarte, California, United States
Contact: Study coordinator (Zorica Simic) · info@coh.org · 6262758069
Contact: Principal Investigator (Jana Portnow, MD)
HOAG, Newport Beach, California, United States
Contact: Study coordinator (Julie Nguyen) · julie.nguyen@hoag.org · 949-764-4577
Contact: Principal Investigator (Simon Khagi, MD)
Baptist MD Anderson Cancer Center, Jacksonville, Florida, United States
Contact: Study coordinator (Andres Alvarez, MD) · CTOinterest@bmcjax.com · 9042027713
Contact: Principal Investigator (Robert Cavaliere, MD)
Cooper University Health Care, Camden, New Jersey, United States
Contact: Study coordinator (Sean Behnke) · Behnke-Sean@CooperHealth.edu · 856-342-2362
Contact: Principal Investigator (Alan Turtz, MD)
Rutgers Cancer Institute, New Brunswick, New Jersey, United States
Contact: Study coordinator (Xiaoru Chen) · xc194@cinj.rutgers.edu · 732-235-2465
Contact: Principal Investigator (Morana Vojnic, MD)
Atlantic Health, Summit, New Jersey, United States
Contact: Study coordinator (Morgan Finlay) · Morgan.finlay@atlantichealth.org · 9085225985
Contact: Principal Investigator (Robert Aiken, MD)
Lenox Hill Hospital, New York, New York, United States
Contact: Study coordinator (Sara Massimo) · smassimo@northwell.edu · 212-434-4482
Contact: Study coordinator (John Boockvar, MD)
UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, United States
Contact: Study coordinator (Claire Kowalczyk) · cancerclinicaltrials@med.unc.edu · 877-668-0683
Contact: Principal Investigator (Dominique Higgins, MD)
Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States
Contact: Study coordinator (Sara Cox) · sara.cox@advocatehealth.org · 336-713-7748
Contact: Principal Investigator (Roy E Strowd III, MD)
The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States
Contact: Study coordinator (Clinical Research Coordinator) · jamesline@osumc.edu · 800-293-5066
Contact: Principal Investigator (J. Bradley Elder, MD)
UPMC Presbyterian Hospital, Pittsburgh, Pennsylvania, United States
Contact: Study coordinator (Theodore Estep) · esteptj2@upmc.edu · 878-261-6727
Contact: Principal Investigator (Costas Hadjipanayis, MS, MD, PhD)
Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States
Contact: Study coordinator (Kathy Taylor) · kathy.l.taylor@vumc.org · 615-875-0060
Contact: Principal Investigator (Ryan Merrell, MD)
UTHealth Houston, Houston, Texas, United States
Contact: Study coordinator (Mia Vu) · mia.vu@uth.tmc.edu · 7134868000
Contact: Principal Investigator (Nitin Tandon, MD)
Baylor College of Medicine, Houston, Texas, United States
Contact: Study coordinator (Glenn Wilson) · ggwilson@bcm.edu · 713-798-2273
Contact: Principal Investigator (Jacob Mandel, MD)
The University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States
Contact: Study coordinator (Leti Velten, RN) · Velten@uthscsa.edu · 210-450-1921
Contact: Principal Investigator (Andrew Brenner, MD, PhD)

צפייה במקור ב־ClinicalTrials.gov